0001203311-23-000097.txt : 20230830 0001203311-23-000097.hdr.sgml : 20230830 20230830190839 ACCESSION NUMBER: 0001203311-23-000097 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230828 FILED AS OF DATE: 20230830 DATE AS OF CHANGE: 20230830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DANSEY ROGER D CENTRAL INDEX KEY: 0001741836 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 231226455 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE CITY: BOTHELL STATE: WA ZIP: 98021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seagen Inc. CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: SEATTLE GENETICS INC /WA DATE OF NAME CHANGE: 20001116 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2023-08-28 0 0001060736 Seagen Inc. SGEN 0001741836 DANSEY ROGER D 21823 30TH DRIVE SE BOTHELL WA 98021 0 1 0 0 President, R&D & CMO 0 Common Stock 2023-08-28 4 A 0 1872 0.0 A 116813 D Common Stock 2023-08-29 4 S 0 1016 206.0 D 115797 D The performance criteria for these restricted stock units were met. These restricted stock units became fully vested on 8/28/2023. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting. The sales reported in this Form 4 were effected pursuant to a written plan adopted on 11/13/2020 that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). By: /s/ Jennifer Prosba For: Roger D. Dansey 2023-08-30